Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Atorvastatin and Anakinra in Kawasaki Disease
NCT04747847Phase 1Completed
- Sponsor
- University of California, San Diego
- Start
- Jun 2019
- Primary completion
- Aug 2022
- Modality
- Cytokines & Interferons, Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of atorvastatin and anakinra in Kawasaki disease (KD), sponsored by University of California, San Diego. Primary endpoint: Number of Participants With Treatment-related Adverse Events at 6 weeks. Started Jun 2019; status: completed.
02
Drugs
atorvastatinanakinra
03
Conditions
Kawasaki disease (KD)
Beyond the preview
Go deeper on NCT04747847.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04747847.